Aktieanalys

Xspray Pharma: Robust Finances – Directed Share Issue Raised SEK 100m - Redeye

{newsItem.title}

Redeye Publicerad: 18 Oct 2022 08:59

Redeye positively views yesterday evening’s news that Xspray, through a directed share issue, has secured SEK 100m in funding, targeting its largest owners and new institutional capital. We leave a comment and adjust our fair value range for the dilution.

Länk till analysen i sin helhet: https://www.redeye.se/research/858374/xspray-pharma-robust-finances-directed-share-issue-raised-sek-100m?utm_source=finwire&utm_medium=RSS

Nyheter om Xspray Pharma

Läses av andra just nu

Om aktien Xspray Pharma

Senaste nytt